SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Drugs >

Elite Pharmaceuticals (ELTP)

ELTP RSS Feed
Add ELTP Price Alert      Hide Sticky   Hide Intro
Moderator: Drugdoctor, dr_lowenstein, lasers, NASDAQ2020, IB_, Chasing
Search This Board: 
Last Post: 11/22/2017 1:35:30 AM - Followers: 835 - Board type: Free - Posts Today: 4

Elite Pharmaceuticals, Inc. (ELTP)

 
About Elite Pharmaceuticals
 
Elite Pharmaceuticals is a specialty pharmaceutical company specializing in niche generics and committed to the development of abuse-deterrent opioids to help curb diversion, misuse and abuse.  Elite has a pipeline of opioid abuse-deterrent products under development utilizing the company’s proprietary pharmacological abuse-deterrent technology. 
 
Located in Northvale, New Jersey, Elite operates a 55,000 square foot campus under Current Good Manufacturing Practice (“cGMP”) and is a United States Drug Enforcement Agency (“DEA”) registered facility for research, development, manufacturing and packaging of pharmaceutical products.
 
More information including Elite’s proprietary Abuse Resistant Technology can be found at http://www.elitepharma.com
 


About Elite's Abuse Deterrent Technology

Elite's abuse deterrent products utilize the Company's proprietary pharmacological abuse deterrent technology. Elite's abuse deterrent technology is a multi-particulate capsule which contains an opioid agonist in addition to naltrexone, an opioid antagonist. Naltrexone is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. When this product is taken as intended, the naltrexone is designed to pass through the body unreleased while the opioid agonist releases over time providing therapeutic pain relief for which it is prescribed. If the multi-particulate beads are crushed, the opioid antagonist, naltrexone, is designed to release. The absorption of the naltrexone is intended to block the euphoria by preferentially binding to same receptors in the brain as the opioid agonist and thereby reducing the incentive for abuse or misuse by recreational drug abusers.
 
Elite continues to expands the intellectual property for the Company's opioid abuse deterrent technology. Elite now has four US patents, one European patent, and two Canadian patents issued in this area with additional patents pending in the U.S., Canada and Europe.
 
Products & Pipeline
 
Screen%20Shot%202017-05-28%20at%2011.53.29%20AM.png
 
Elite’s principle product is SequestOx, an immediate-release oxycodone with sequestered naltrexone abuse-deterrent opioid product for the management of moderate to severe acute pain. Additional products include bariatric, cardiovascular, antihistamine, skeletal muscle relaxants, antipsychotic, tricyclic antidepressant, along with a number of approved products pending manufacturing site transfer.
 
Elite owns generic and OTC products which have been licensed to TAGI Pharma, Epic Pharma, Dr. Reddy's Laboratories and Valeant Pharmaceuticals International. Additional information regarding Elite’s wholly owned products, partnerships, and contract manufacturing can be found at  http://www.elitepharma.com/products
 
The list of pipeline products can be found at http://www.elitepharma.com/pipeline-generics
 
Leadership
 
Nasrat Hakim, Chairman, President & Chief Executive Officer
 
Nasrat Hakim joined Elite in August 2013 as Director, President and Chief Executive Officer. Mr. Hakim has more than 30 years of pharmaceutical and medical industry experience in Quality Assurance, Analytical Research and Development, Technical Services and Regulatory Compliance. He brings with him proven management experience, in-depth knowledge of manufacturing systems, development knowledge in immediate and extended release formulations and extensive regulatory experience of GMP and FDA regulations. Prior to his leading Elite, from 2004 to 2013, Mr. Hakim was employed by Actavis, Watson and Alpharma in various senior management positions. Most recently, Mr. Hakim served as International Vice President of Quality Assurance at Actavis, overseeing 25 sites with more than 3,000 employees under his leadership.  Mr. Hakim also served as Corporate Vice President of Technical Services, Quality and Regulatory Compliance for Actavis U.S., Global Vice President, Quality and Regulatory Compliance for Alpharma, as well as Executive Director of Quality Unit at TheraTech, overseeing manufacturing and research and development. In 2009, Mr. Hakim founded Mikah Pharma, LLC, a virtual, fully functional pharmaceutical company. 

Mr. Hakim’s career started in Medical Laboratory Technology from the Academy of Health and Sciences in the U.S. Army based in San Antonio, TX, followed by Graduate Certification in Regulatory Affairs (RAC) from California State University at Sacramento, Sacramento, CA; Bachelor in Chemistry/Bio-Chemistry and Masters of Science in Chemistry from California State University at Sacramento, Sacramento, CA; and a Masters in Law with Graduate Certification in U.S. Taxation from St. Thomas University, School of Law, Miami, FL.
 

Investor Relations and Corporate Inquiries

Dianne Will
Vice President of Investor Relations and Corporate Affairs
Telephone: 518-398-6222
Email: 
dianne@elitepharma.com

Corporate Headquarters
165 Ludlow Avenue
Northvale, New Jersey 07647
Phone: 201-750-2646
Fax: 201-750-2755


 

Miscellaneous Links:
 
Elite Pharmaceuticals News
http://ir.elitepharma.com/press_releases
 
SEC Filings
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001053369&owner=include

FDA website
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails

Clinical Trials.Gov
https://www.clinicaltrials.gov/
 
Yahoo Finance
https://finance.yahoo.com/quote/ELTP/?p=ELTP
 
Seeking Alpha
https://seekingalpha.com/symbol/ELTP
 

ELTP Daily Chart
    


SureTrader
Interactive Brokers Advertisement
ELTP
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ELTP News: Current Report Filing (8-k) 11/09/2017 05:05:42 PM
ELTP News: Quarterly Report (10-q) 11/09/2017 04:53:40 PM
ELTP News: Confidential Treatment Order (ct Order) 10/11/2017 12:26:51 PM
ELTP News: Current Report Filing (8-k) 09/07/2017 04:32:57 PM
ELTP News: Current Report Filing (8-k) 08/09/2017 05:01:18 PM
PostSubject
#277171  Sticky Note Links for November 10th Conference Call transcript/replay Chasing 11/12/17 01:57:56 PM
#275620  Sticky Note Let's talk Nasrat's "Strategy" for a minute. Play Mazeppa 10/30/17 01:49:46 PM
#274770  Sticky Note memorable "calls" for elite pharma: dr_lowenstein 10/24/17 04:09:11 PM
#271038  Sticky Note Elite Pharma at Pain Week 2017 NASDAQ2020 09/17/17 04:03:01 PM
#234937  Sticky Note THIS IS WHAT YOU NEED TO KNOW BEFORE Couch 11/30/16 03:04:07 PM
#189564  Sticky Note $ELTP SequestOx and ADF Patents lasers 03/18/16 04:29:26 AM
#185967  Sticky Note The only topic here is ELTP. IH Dan (Retired) 02/23/16 09:32:46 PM
#278248   It's in the only interest of MM's to stockboy 11/22/17 01:35:30 AM
#278247   Already 10 approved ADF's so far and I stockboy 11/22/17 01:32:43 AM
#278246   You have to sign up to Seeking alpha sharkey1 11/22/17 01:00:54 AM
#278245   FDA issues guidance on development of generic abuse-deterrent opioids conix 11/22/17 12:01:17 AM
#278244   Damn autocorrect. That’s buying more every time BostonTrader 11/21/17 10:34:37 PM
#278243   Most longs on this board are way way BostonTrader 11/21/17 10:33:47 PM
#278242   Didn’t last. Another day it failed to BostonTrader 11/21/17 10:30:27 PM
#278241   Its being shorted every trading day and they newguy11 11/21/17 09:41:43 PM
#278240   interesting, but irrelevant to elite as those stats dr_lowenstein 11/21/17 08:46:21 PM
#278239   They met with the CHINESE and turned the stockboy 11/21/17 07:58:06 PM
#278238   3 for 3 and a WARNING LETTER TO stockboy 11/21/17 07:56:50 PM
#278237   Answers? How about the following link? https://finance.yahoo.com/news/fda-approved-fewer-drugs-2016 no2koolaid 11/21/17 07:52:50 PM
#278236   I'm hoping Elite truck was out making deliveries IB_ 11/21/17 07:50:39 PM
#278233   Let's give some (likes) on the news release sharkey1 11/21/17 07:29:01 PM
#278232   IB, very well could be at 10 cents soon enough! snupoled 11/21/17 07:27:55 PM
#278231   So it's been shorted all along because YJ4LIFE 11/21/17 06:32:14 PM
#278230   I DID NOT SEE THE TRUCK steve9465 11/21/17 06:19:59 PM
#278229   I asked Schwab if ELTP is being shorted. elichen 11/21/17 06:19:08 PM
#278224   Damn I knew the building they rented was stockboy 11/21/17 05:24:36 PM
#278223   They would be embarASSed with a float of stockboy 11/21/17 05:24:06 PM
#278221   Yes and don't forget Elite in dollar land IB_ 11/21/17 05:17:58 PM
#278218   Elite was going to $5.00 in 2011, but IB_ 11/21/17 05:11:32 PM
#278217   Wasn't that said for 2014, 2015, 2016, 2017 stockboy 11/21/17 05:11:00 PM
#278216   ELTP looking good up +.0001 .0781 YAHOO YIPPEE stockboy 11/21/17 05:08:33 PM
#278215   Pps barely .07 E92M 11/21/17 03:57:31 PM
#278213   Yes, as much as 2016 was as well. jour_trader 11/21/17 03:17:29 PM
#278210   Wow pictures of a building!!... namtae 11/21/17 03:01:05 PM
#278209   The FDA is also assessing the abuse deterrent NASDAQ2020 11/21/17 02:46:00 PM
#278208   Will 2018 be Elites Year !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! IB_ 11/21/17 02:45:07 PM
#278207   Thxs to $ELTP for having a superb 55,000 lasers 11/21/17 02:28:28 PM
#278206   Eventually this thing is going to explode to Dubster watching 11/21/17 02:22:51 PM
#278205   I'm sure we will be told they are YJ4LIFE 11/21/17 02:21:19 PM
#278204   I'm sure we will be told they are newguy11 11/21/17 02:18:14 PM
#278203   $ELTP 55,000 sq ft facilities looking great. LOVE YJ4LIFE 11/21/17 02:14:59 PM
#278202   That's what I have been hearing until I YJ4LIFE 11/21/17 02:13:11 PM
#278201   Elite needs some pictures of a fork lift IB_ 11/21/17 02:10:27 PM
#278200   That can't be I was told Elite was newguy11 11/21/17 02:09:19 PM
#278198   $ELTP Photos update YJ4LIFE 11/21/17 02:04:18 PM
#278197   I think Elite may get back to $0.10 IB_ 11/21/17 02:03:58 PM
#278195   ADF guidance statement doc link: https://www.fda.gov/downloads/Drugs/GuidanceCom jgsnys 11/21/17 01:53:39 PM
#278194   Yes they do. lasers 11/21/17 01:52:46 PM
#278193   The facilities look great! senderos 11/21/17 01:51:34 PM
#278191   Pics don't lie. sharkey1 11/21/17 01:27:45 PM
#278190   Looking good lasers 11/21/17 01:25:49 PM
#278189   $ELTP 55,000 sq ft facilities looking great. lasers 11/21/17 01:24:06 PM
#278187   $$$$ 20 Pathways to DollarLand $$$$ NASDAQ2020 11/21/17 01:13:36 PM
#278183   ROFLMAO stockboy 11/21/17 12:37:03 PM
#278182   Real pictures too bad he wasn't so transparent stockboy 11/21/17 12:30:49 PM
#278181   Looking good thanks lasers Gman24 11/21/17 12:28:10 PM
#278180   Covering, looks like 1.8 million more shares shorted newguy11 11/21/17 12:12:24 PM
PostSubject